A Study of Enicepatide (CT-388) in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus
Clinical trial NCT06628362 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06628362
- Sponsor
- Carmot Therapeutics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-21
- Primary completion
- 2026-05-29
- Enrollment
- 447
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.